1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,011 | 0,033 | 15.10. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| Mo | Composition of Bioretec's Shareholders' Nomination Board | 1 | Cision News | ||
| 08.10. | Bioretec Oy: Inside information: Bioretec initiates change negotiations to improve operational efficiency and competitiveness | 211 | GlobeNewswire (Europe) | Bioretec Ltd, Inside Information, 8 October 2026 at 4:00 p.m. EEST
Bioretec Ltd will initiate change negotiations in accordance with the Co-operation Act as part of the development of the company's... ► Artikel lesen | |
| 05.09. | Bioretec Oy: Bioretec receives FDA 510(k) clearance for its ActivaScrew Cannulated COM bioabsorbable compression screw | 276 | GlobeNewswire (Europe) | Bioretec Ltd. | Inside information | 5 September 2026 at 12:25 p.m. EEST
Bioretec Ltd ("Bioretec" or the "Company"), a pioneer in bioabsorbable orthopedic implants, has received 510(k) clearance from... ► Artikel lesen | |
| 13.08. | Bioretec Oy: Bioretec Ltd's Half-year report 2026: H1 close signals momentum | 313 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 13 August 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's half-year report for January-June 2026. The complete half-year report is attached to this... ► Artikel lesen | |
| 05.08. | Bioretec Oy: Panu Mikkonen appointed as Chief Financial Officer of Bioretec | 322 | GlobeNewswire (Europe) | Bioretec Ltd | Company announcement | 5 August 2026 at 4:00 p.m. EESTBioretec Ltd, a pioneer in absorbable orthopedic implants, appoints Panu Mikkonen (M.Sc. Econ) as Chief Financial Officer, effective... ► Artikel lesen | |
| 02.07. | Bioretec Oy: Inside information: Chief Financial Officer Tuukka Paavola will leave the company | 509 | GlobeNewswire (Europe) | Bioretec Ltd, Inside Information, 2 July 2026 at 14.30 EESTBioretec Ltd and Tuukka Paavola have mutually agreed that Paavola will not continue in his position. Paavola will leave his role with immediate... ► Artikel lesen | |
| 17.06. | Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team | 2 | Cision News | ||
| 17.06. | Bioretec concludes change negotiations | 2 | Cision News | ||
| 04.06. | Bioretec Ltd - Manager's transactions - van Hellenberg Hubar-Fisher | 4 | Cision News | ||
| 02.06. | Bioretec Ltd - Manager's transactions - Jordy Winters | 331 | PR Newswire | TAMPERE, Finland, June 2, 2026 /PRNewswire/ -- Bioretec Oy Company release 2 June 2026 at 13:25 p.m. EEST
Bioretec Oy - Managers' TransactionsPerson subject to the notification requirementName:... ► Artikel lesen | |
| 01.06. | Inside information: Bioretec initiates new change negotiations in production to enhance operational efficiency | 485 | PR Newswire | Bioretec Ltd - Inside information - 1 June 2026 at 19:00 EESTTAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd initiates change negotiations in accordance with the Finnish Act on... ► Artikel lesen | |
| 01.06. | The Board of Directors of Bioretec Ltd resolved on a new stock option plan | 451 | PR Newswire | TAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd Company Announcement -1 June 2026 at 19:05 p.m. EEST
The Board of Directors of Bioretec Ltd has resolved to establish a new... ► Artikel lesen | |
| 15.05. | Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 633 | PR Newswire | TAMPERE, Finland, May 15, 2026 /PRNewswire/ -- Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March... ► Artikel lesen | |
| 15.05. | Bioretec Oy: Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 477 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March 2026. The complete business review is attached to this... ► Artikel lesen | |
| 13.05. | Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 525 | PR Newswire | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EESTHELSINKI, May 13, 2026 /PRNewswire/ -- To be aligned with industry reporting standards, Bioretec will transition to reporting an... ► Artikel lesen | |
| 13.05. | Bioretec Oy: Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 321 | GlobeNewswire (Europe) | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EEST
Bioretec clarifies its 2026-2028 financial target regarding the sales marginTo be aligned with industry reporting standards, Bioretec will... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors | 533 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 20:40 p.m. EEST
Bioretec Ltd's resolutions of the constitutive meeting of the Board of DirectorsAt its... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the Annual General Meeting | 566 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting Bioretec Ltd's Annual General... ► Artikel lesen | |
| 08.05. | Bioretec Oy: Bioretec Ltd's resolutions of the Annual General Meeting | 290 | GlobeNewswire (Europe) | Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting
Bioretec Ltd's Annual General Meeting was held on Friday 8 May 2026 as a hybrid... ► Artikel lesen | |
| 29.04. | Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Sp-Rahastoyhtiö) | 405 | PR Newswire | HELSINKI, April 29, 2026 /PRNewswire/ -- Bioretec Ltd Company release 29 April 2026 at 16:40 p.m. EEST
Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities... ► Artikel lesen |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,320 | +0,16 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler und TerThera unterzeichnen Liefervertrag, der brasilianischen Patienten GMP-konforme Terbium-161-Radiopharmaka der nächsten Generation zugänglich macht. | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vertrag
Eckert & Ziegler und TerThera unterzeichnen Liefervertrag, der brasilianischen Patienten GMP-konforme Terbium-161-Radiopharmaka... ► Artikel lesen | |
| INTUITIVE SURGICAL | 381,80 | +0,05 % | ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell? | ||
| DRAEGERWERK | 96,30 | -17,41 % | Draegerwerk AG & Co. KGaA: Sechsjähriger FDA-Belastungsfaktor beseitigt; US-Monitoring-Geschäft rückt wieder in den Fokus; KAUFEN | Dräger hat ein sechs Jahre währendes regulatorisches Kapitel im US-Patientenmonitoring endlich abgeschlossen. Nach der FDA-Freigabe (Clearance) von Dräger IACS VG8.1 hat die Behörde den 2020 ausgesprochenen... ► Artikel lesen | |
| INSULET | 124,00 | +0,08 % | Insulet's Omnipod Discover data platform begins full US rollout | ||
| CYTOSORBENTS | 3,000 | 0,00 % | Cytosorbents Corp: CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement | PRINCETON, N.J., Sept. 23, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac... ► Artikel lesen | |
| GENEDX | 70,31 | +0,13 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| REVENIO GROUP | 11,060 | -0,36 % | Revenio Group Corporation: Final result of Revenio Group Corporation's rights offering | Revenio Group Corporation | Stock Exchange Release | October 15, 2026 at 18:45:00 EEST
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, UNITED KINGDOM... ► Artikel lesen | |
| OPTOMED | 1,370 | -1,30 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| FRESENIUS | 43,855 | +0,68 % | VW und Autobauer im Fokus: DAX vor dem nächsten Schub? Diese Woche wird für Anleger entscheidend | © Foto: Boris Roessler/dpaDer DAX dürfte freundlich in die neue Woche starten. Auch die europäischen Futures liegen im Plus. Doch Öl, Inflation und die beginnende US-Berichtssaison könnten schnell für... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,850 | +1,95 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,150 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,460 | +2,95 % | Fresenius Medical Care AG: Kurzfristige Gegenwinde zunehmend eingepreist; Hochstufung auf KAUFEN | Fresenius Medical Care (FME) hat die Prognose für das Geschäftsjahr 2026 bestätigt, wobei auslaufende TDAPA-Effekte, schwache Behandlungsvolumina in den USA und Restrukturierungsaufwendungen das Ergebnis... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,37 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 50,84 | -0,13 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 102,73 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026 |
BIORETEC OY gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.